A Popular Sunscreen Ingredient Used in Europe Could Be Coming to the US

Bemotrizinol has proved safe and effective and may be available by the end of 2026

Combination Therapy Before Surgery Shows Promise for Aggressive Skin Cancer

Moffitt-led study explores how pairing lenvatinib and pembrolizumab strengthens immune response against Merkel cell carcinoma

Experimental Injectable Therapy Offers Nonsurgical Treatment of Common Skin Cancer

Phase 2 study led by Moffitt researchers finds VP-315 triggers strong local and systemic immune response against basal cell carcinoma

Moffitt’s New Brachytherapy Suite Provides More Efficient Radiation Treatment

The space opens on Oct. 22 and offers a better way to treat cancer and spare healthy tissues

September Cancer Screening Event Comes to Childs Park in St. Petersburg

Moffitt partners with other health care organizations to offer a range of free cancer screenings Sept. 13

President Biden Undergoes Surgery for Skin Cancer on His Forehead

He received Mohs surgery, which is used to remove basal cell and squamous cell carcinoma

Single-Drug Immunotherapy Shows Success in Rare Skin Cancer

Pembrolizumab delivers 89% response rate in desmoplastic melanoma, sparing patients from harsher combination treatments

No, TikTok, Sunburn Tattoos Are Not a Cool or a Good Idea

A new trend encourages frequent tanning to create patterns on the skin

Overcoming Melanoma as a Teenager

Treated as a pediatric patient at Moffitt, Kevin Rizzo is now healthy and thriving at 25

Endeavor